Unaudited Consolidated Statement of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Cash flows from operating activities:
Net loss	$ (1,272,008)	$ (707,618)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of debt discounts	150,238	147,128
Loss on monetization agreement		59,811
Gain on derivative	25,000	(40,000)
Depreciation and amortization	333,290	226,846
Changes in operating assets and liabilities
Accounts receivable	(3,204)	38,358
Accrued interest - loans payable related party	309,702	195,470
Accrued interest - loans payable third party	12,225	12,225
Other current assets	533	533
Accounts payable and accrued expenses	86,267	1,464
Net cash used in operating activities	(357,957)	(65,783)
Cash flows from investing activities
Purchase of patents	(20,000)
Net cash provided by investing activities	(20,000)
Cash flows from financing activities
Proceeds from loans-related party	250,000
Net cash provided by financing activities	250,000
Net decrease in cash and cash equivalents	(127,957)	(65,783)
Cash and cash equivalents at beginning of year	165,546	208,324
Cash and cash equivalents at end of year	37,589	142,541
Cash paid during the year for:
Income taxes including foreign taxing authorities withheld taxes of $1,039,900 and $101,250 during the period ended September 30, 2018, and 2017 respectively.	1,040,125	105,410
Interest
Non-cash investing and financing activity:
Loan proceeds paid directly from lender to seller of patents		25,000
Accounts payable for purchase of patent, net of imputed interest of $202,522		$ 772,478